Catherine Bardelle

Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective

Mei Ding, Roger Clark, Catherine Bardelle, 2018, SLAS discovery : advancing life sciences R & D.

Inhibitors of the tyrosine kinase EphB4. Part 2: structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines.

Jon Read, Andrew G. Leach, Andrew G Leach, 2008, Bioorganic & medicinal chemistry letters.

Development of a High-Content High-Throughput Screening Assay for the Discovery of ATM Signaling Inhibitors

Catherine Bardelle, J. Boros, C. Bardelle, 2012, Journal of biomolecular screening.

Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides

Paul Harper, Louise Ford, John Archer, 2019, Nature Communications.

Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.

Jon Read, Andrew G. Leach, Andrew G Leach, 2008, Bioorganic & medicinal chemistry letters.